PROCEEDINGS OF THE SHEVCHENKO SCIENTIFIC SOCIETY

Chemical Sciences

Archive / Volume LX 2020

Liliya BAZYLYAK, Andriy KYTSYA, Ilona KARPENKO, Olena KARPENKO

Department of Physical Chemistry of Fossil Fuels of the Institute of Physical-Organic Chemistry and Coal Chemistry named after L. M. Lytvynenko of the National Academy of Sciences of Ukraine Naukova Str. 3а, 79060, Lviv, Ukraine e-mail: bazyljak.L.I@nas.gov.ua

DOI: https://doi.org/10.37827/ntsh.chem.2020.60.127

SYNTHESIS AND ANTIMICROBIAL ACTIVITY OF SILVER NANOPARTICLES STABILIZED BY CITRATE ANIONS

Widespread use of synthetic antimicrobial drugs leads to the development of antibiotic resistance of pathogenic strains of microorganisms. Therefore, today researchers are very interested in drugs based on nanoparticles of metals, in particular silver and copper, which have antibacterial, antifungal and antiviral activity. One of the reasons for the high interest of researchers in AgNPs as an antimicrobial agent is the significantly lower toxicity of AgNPs compared to Ag+ ions. High antibacterial efficiency of silver nano¬particles is achieved due to their developed surface, which provides maximum contact with the environment. In addition, such nanoparticles are quite small and are able to penetrate cell membranes, to affect intracellular processes from within. Therefore, the aim of this work was to obtain concentrated colloidal silver solutions stabilized by citrate anions, which simultaneously provide satisfactory stabilization of colloidal silver solutions and are non-toxic, as well as to investigate the antimicrobial action of synthesized AgNPs.
The solution of citrate stabilized silver nanoparticles (AgNPs) have been obtained via the reaction of reduction of silver nitrate by hydrazine in alkaline medium in the presence of sodium citrate. AgNPs were investigated using transmission electron microscopy (TEM) and UV-vis spectroscopy and the particles size and particles size distribution (PSD) were determined. It was observed that obtained AgNPs are mainly spherical shape. It was found that the mean diameter and PSD of AgNPs determined using TEM and UV-vis spectroscopy are close and equal to 14 and 5 nm and 15 and 4 nm respectively. Obtained solution was concentrated by evaporation at 70 °C under reduced pressure up to achievement of AgNPs concentration equal to 200 mg/L. On the base of comparison of optical properties of initial silver sol and concentrated solution the minority of agglomeration of AgNPs was statement. At the same time AgNO3 test showed no change of UV-vis spectrum of concentrate that points on the absence of reducing agent in the solution; this fact indicate that hydrazine was eliminated from during the evaporation of initial AgNPs solution and obtained concentrate did not consist the toxic impurities. Antimicrobial activity of obtained citrate stabilised AgNPs against Gram-positive Bacillus subtilis and Gram-negative Escherichia coli bacterium was tested using disk diffusion method. It was found that AgNPs shown significant bactericidal effect even at low (25 mg/L) concentration as well as some higher efficiency against Gram-negative bacterium. There was also a slightly higher antimicrobial activity of the drug against gram-negative bacteria Escherichia coli compared with gram-positive bacteria Bacillus subtilis, due to the different structure of cell walls. In particular, the walls of gram-positive bacteria consist mainly of peptidoglycan (murein), and gram-negative bacteria have cell walls with a layer of peptidoglycan and an outer membrane with a lipopolysaccharide component, which is not present in gram-positive bacteria. Based on the studies, it can be concluded that the proposed method of synthesis of AgNPs is suitable for obtaining highly concentrated silver sols. This method of synthesis is simple in hardware design, scalable, and the resulting colloidal solutions are stable and do not contain harmful impurities. Therefore, due to the high antibacterial activity of citrate-anion-stabilized AgNPs against certain types of gram-positive and gram-negative bacteria, it can be recommended for the manufacture of bactericidal drugs for biomedical purposes.

Keywords: silver nanoparticles, synthesis, antimicrobial activity.

References:

    1. Franci G., Falanga A., Galdiero S., Palomba L., Rai M., Morelli G., Galdiero M. Silver na-noparticles as potential antibacterial agents. Molecules. 2015. Vol. 20. P. 8856–8874. (https://doi.org/10.3390/molecules20058856).
    2. Anjum S., Abbasi B., Shinwari Z. Plant-mediated green synthesis of silver nanoparticles for biomedical applications: challenges and opportunities. Pak. J. Bot. 2016. Vol. 48. P. 1731–1760.
    3. Srikar S., Giri D., Pal D., Mishra P., Upadhyay S. Green synthesis of silver nanoparticles: A Review. Green Sustain. Chem. 2016. Vol. 6. P. 34–56. (https://doi.org/10.4236/gsc.2016.61004).
    4. Skladanowski M., Golinska P., Rudnicka K., Dahm H., Rai M. Evaluation of cytotoxicity, immune compatibility and antibacterial activity of biogenic silver nanoparticles. Med. Microbiol. Immunol. 2016. Vol. 205. P. 603–613. (https://doi.org/10.1007/s00430-016-0477-7).
    5. Zain N., Stapley A., Shama G. Green synthesis of silver and copper nanoparticles using as-corbic acid and chitosan for antimicrobial applications. Carbohydr. Polym. 2014. Vol. 112. P. 195–202. (https://doi.org/10.1016/j.carbpol.2014.05.081).
    6. Krutyakov Yu. А., Kudrinskiy А. А., Olenin A. Yu., Lisichkin G. V. Synthesis and properties of silver nanoparticles: achievements and prospects. Success. Chem. 2008. Vol. 77(3). P. 242–269 (in Russian). (https://doi.org/10.1070/RC2008v077n03ABEH003751).
    7. Lytvyn V. A. Synthesis and properties of silver and gold nanoparticles stabilized with syn-thetic humic substances: PhD Thesis. – Lviv. 2013. 156 p. (in Ukrainian).
    8. Tripathi R. M., Saxena A., Gupta N., Kapoor H., Singh R. P. High antibacterial activity of silver nanoballs against E. Coli MTCC 1302, S. Typhimurium MTCC 1254, B. Subtilis MTCC 1133 and P. Aeruginosa MTCC 2295. Dig. J. Nanomater. Biostruct. 2010. Vol. 5(2). P. 323–330.
    9. Szczepanowicz K., Stefanska J., Socha R., Warszynski P. Preparation of silver nanoparticles via chemical reduction and their antimicrobial activity. Physicochem. Probl. Miner. Process. 2010. Vol. 45. P. 85–98.
    10. Panáček A., Smékalová M., Večeřová R., Bogdanová K., Röderová M., Kolář M., Kiliano-vá M., Hradilová Š., Froning Jens P., Havrdová M., Prucek R., Zbořil R., Kvítek L. Silver nanopar-ticles strongly enhance and restore bactericidal activity of inactive antibiotics against multiresistant Enterobacteriaceae. Colloid. Surfaces B. 2016. Vol. 142. P. 392–399. (https://doi.org/10.1016/j.colsurfb.2016.03.007).
    11. Galdiero S., Falanga A., Vitiello M., Cantisani M., Marra V., Galdiero M. Silver nanopar-ticles as potential antiviral agents. Molecules. 2011. Vol. 16(10). P. 8894–8918. (https://doi.org/10.3390/molecules16108894).
    12. Zhang X. F., Liu Z. G., Shen W., Gurunathan S. Silver nanoparticles: synthesis, charac-terization, properties, applications, and therapeutic approaches. Int. J. Mol. Sci. 2016. Vol. 17(9). P. 1534. (https://doi.org/10.3390/ijms17091534).
    13. Wei L., Lu J., Xu H., Patel A., Chen Z. S., Chen G. Silver nanoparticles: synthesis, pro-perties, and therapeutic applications. Drug Discov. Today. 2015. Vol. 20(5). P. 595–601. (https://doi.org/10.1016/j.drudis.2014.11.014).
    14. Abbasi E., Milani M., Fekri Aval S., et al. Silver nanoparticles: synthesis methods, bioap-plications and properties. Crit. Rev. Microbiol. 2016. Vol. 42. P. 173–180. (https://doi.org/10.3109/1040841X.2014.912200).
    15. Li Q., Mahendra S., Lyon D. Y., et al. Antimicrobial nanomaterials for water disinfection and microbial control: potential applications and implications. Water Res. 2008. Vol. 42(18). P. 4591–4602. (https://doi.org/10.1016/j.watres.2008.08.015).
    16. Li Y., Wu Y., Ong B. S. Stabilized silver nanoparticles and their use. US Patent US7270694B2. 2007.
    17. Nabutovsky Y., Bornzin G. A., Karicherla A., et al. Silver nanoparticle antimicrobial co-ating for long-term and short-term infection resistance. US Patent US8647675B2. 2014.
    18. Karandikar B., Gibbins B., Cornell K. Antimicrobial silver compositions. US Patent US20070003603A1. 2007.
    19. Qiu Y., Qian X. Antimicrobial medical devices including silver nanoparticles. Patent WO2008094876A1. 2008.
    20. Bikel M., Erkel J. V. Antimicrobial membrane containing silver nanoparticles. US Patent US20130299428A1. 2013.
    21. Xing Z. C., Chae W. P., Baek J. Y., Choi M. J., Jung Y., Kang I. K. In vitro assessment of antibacterial activity and cytocompatibility of silver-containing PHBV nanofibrous scaffolds for tissue engineering. Biomacromolecules. 2010. Vol. 11(5). P. 1248–1253. (https://doi.org/10.1021/bm1000372).
    22. Morley K., Webb P., Tokareva N., et al. Synthesis and characterization of advanced UHM– WPE silver nanocomposites for biomedical applications. Eur. Polymer J. 2007. Vol. 43(2). P. 307–314. (https://doi.org/10.1016/j.eurpolymj.2006.10.011).
    23. Berger T. J., Spadaro J. A., Chapin S. E., Becker R. O. Electrically generated silver ions: quantitative effects on bacterial and mammalian cells. Antimicrob. Agents Chemother. 1976. Vol. 9(2). P. 357–358. (https://doi.org/10.1128%2Faac.9.2.357).
    24. State sanitary norms and rules. Hygienic requirements for drinking water intended for human consumption: SSanN&R 2.2.4-171-10 (2019) [Valid from 28-12-2019]. – State Sanitary and Epidemiological Service of Ukraine.
    25. Petritskaya E. N., Abaeva L. F., Rogatkin D. А., Litvinova K. S., Bobrov M. А. On the to-xicity of silver nanoparticles by oral administration of a colloidal solution. Clin. Med. Almanac. 2011. Vol. 25. P. 9–12 (in Russian).
    26. Kytsya A. R., Reshetnyak O. V., Bazylyak L. I., Hrynda Yu. M. Extinction spectra of aqueous sols of silver nanoparticles as a characteristic of their size and polydispersity. J. Nano-Electron. Phys. 2013. Vol. 5(4). P. 04064 (1–4) (in Ukrainian).
    27. Kytsya A. R., Bazylyak L. I., Reshetnyak O. V., Hrynda Yu. M., Chaikivskiy T. V. The method of determining the size of silver nanoparticles. Ukrainian patent № 85539. 2013. (in Ukrainian).
    28. Kytsya A. R., Bazylyak L. I., et al. Synthesis of silver nanoparticles and determination of their size and polydispersity by surface plasmon resonance spectra: educational and methodical manual on discipline «Nanostructures» [for the students of the V course of chemist. faculty, educational qualification Master's level]. – Lviv.: Publ. center of Lviv National University, 2014. 64 p. (in Ukrainian).
    29. Muromtsev G. S. Methods of soil microbiology. – Moscow: Kolos, 1983. 296 p. (in Russian).
    30. Manual «Determination of sensitivity of microorganisms to antibacterial drugs». Kyiv: Ministry of Health of Ukraine, 2007. 70 p. (in Ukrainian).
    31. Kytsya A., Bazylyak L., Hrynda Y., Horechyy A., Medvedevdkikh Y. The kinetic rate law for the autocatalytic growth of citrate-stabilized silver nanoparticles. Int. J. Chem. Kinet. 2015. Vol. 47. P 351–360. (https://doi.org/10.1002/kin.20913).
    32. Kytsya A. R., Bazylyak L. I., Hrynda Y. M., Medvedevskikh Y. G. An influence of kinetic parameters of reaction on the size of obtained nanoparticles under reduction of silver ions by hydrazine. In: Zaikov G. E., Bazylak L. I., Haghi A. K. (eds) Functional Polymer Blends and Nanocomposites: A Practical Engineering Approach. Apple academic press, Toronto, New Jersey. 2014. P. 255–262. (https://doi.org/10.1201/b16895).
    33. Lu Z., Rong K., Li J., Yang H., Chen R. Size-dependent antibacterial activities of silver nanoparticles against oral anaerobic pathogenic bacteria. J. Mater. Sci.: Mater. Med. 2013. Vol. 24(6). P. 1465–1471. (https://doi.org/10.1007/s10856-013-4894-5).

How to Cite

Bazylyak L., Kytsya A., Karpenko I., Karpenko O. SYNTHESIS AND ANTIMICROBIAL ACTIVITY OF SILVER NANOPARTICLES STABILIZED BY CITRATE ANIONS Proc. Shevchenko Sci. Soc. Chem. Sci. 2020 Vol. LX. P. 127-135.

Download the pdf